Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Ginkgo Bioworks Holdings Inc’s stock clocked out at $7.95, down -2.33% from its previous closing price of $8.14. In other words, the price has decreased by -$2.33 from its previous closing price. On the day, 0.85 million shares were traded. DNA stock price reached its highest trading level at $8.1299 during the session, while it also had its lowest trading level at $7.68.
Ratios:
To gain a deeper understanding of DNA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.79 and its Current Ratio is at 5.79. In the meantime, Its Debt-to-Equity ratio is 0.56 whereas as Long-Term Debt/Eq ratio is at 0.56.
Raymond James Downgraded its Outperform to Mkt Perform on November 14, 2023, whereas the target price for the stock was revised from $3.50 to $2.50.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 26 ’24 when Che Austin bought 99 shares for $8.01 per share.
Che Austin bought 99 shares of DNA for $734 on Nov 25 ’24. On Nov 22 ’24, another insider, Che Austin, who serves as the Officer of the company, bought 99 shares for $6.64 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNA now has a Market Capitalization of 456957248 and an Enterprise Value of 272836288. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.10 while its Price-to-Book (P/B) ratio in mrq is 0.50. Its current Enterprise Value per Revenue stands at 1.252 whereas that against EBITDA is -0.519.
Stock Price History:
Over the past 52 weeks, DNA has reached a high of $75.20, while it has fallen to a 52-week low of $5.26. The 50-Day Moving Average of the stock is 0.64%, while the 200-Day Moving Average is calculated to be -64.27%.
Shares Statistics:
It appears that DNA traded 1.35M shares on average per day over the past three months and 1781060 shares per day over the past ten days. A total of 38.13M shares are outstanding, with a floating share count of 37.16M. Insiders hold about 31.79% of the company’s shares, while institutions hold 47.98% stake in the company. Shares short for DNA as of 1730332800 were 7326663 with a Short Ratio of 5.44, compared to 1727654400 on 8187416. Therefore, it implies a Short% of Shares Outstanding of 7326663 and a Short% of Float of 23.49.
